Pursuant to Regulation 30 of the SEBI Listing Regulations, Caplin Point Laboratories has informed that the Board of Directors of Caplin Steriles, a material Subsidiary of the Company, had approved the incorporation of a wholly owned subsidiary in the US, at the meeting of its Board held yesterday August 02, 2023. The details required under regulation 30 of SEBI (LODR) Regulations, 2015 read with SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023 are enclosed as Annexure A.
The above information is a part of company’s filings submitted to BSE.
